StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3025% above fair value
$0.37−0.01 (-3.52%)

Close on Nov 20, 2026Market cap $75.75MP/E –Yield –

Lucid Diagnostics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Lucid Diagnostics's gross profit for the twelve months ending Dec 31, 2022 was $377.00K, down 24.6% year over year. For fiscal 2025 it was -$1.96M.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.96M–
FY2024Dec 31, 2024-$2.75M-830.2%
FY2022Dec 31, 2022$377.00K-24.6%
FY2021Dec 31, 2021$500.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$29.00K-74.1%
Q1 FY2026Mar 31, 2026-$369.00K-585.5%
Q2 FY2025Jun 30, 2025-$400.00K–
Q1 FY2025Mar 31, 2025-$723.00K–
Q4 FY2022Dec 31, 2022$112.00K-62.7%
Q3 FY2022Sep 30, 2022$76.00K-62.0%
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022-$180.00K–
Q4 FY2021Dec 31, 2021$300.00K–
Q3 FY2021Sep 30, 2021$200.00K–

More Lucid Diagnostics figures

See a number that looks wrong?